NeoX
NeoX (NeoX株式会社) is a Japanese AI company that provides AI-OCR prescription reading and Smart Pharmacy workflow automation to over 7,000 pharmacy stores in Japan, powered by its proprietary MoAir visual understanding platform.
- Company typePrivate
- Founded2016
- HeadquartersTokyo (Shibuya), Japan
- Headcount—
- GTM typeB2B
- OfferingSoftware
What NeoX does
NeoX株式会社 (NeoX Inc.) is a Japanese AI company founded in 2016-2017 by CEO He Shumian (何書勉), a Kyoto University PhD in Informatics and former Rakuten Executive Officer. The company is headquartered in Shibuya, Tokyo, with registered capital of 5,000,000 JPY, and operates as a privately held corporation. NeoX develops AI-powered visual understanding technology through its proprietary MoAir platform, which combines object recognition, OCR, and 1D/2D code scanning on a smartphone-based edge architecture that enables non-engineers to build visual AI models through a GUI interface. The platform supports cross-platform deployment across iOS, Android, Linux, and JavaScript browsers.
The company's commercial focus has shifted decisively to Japanese healthcare DX since 2020, anchored by 薬師丸賢太 (Yakumaru Kenta), an AI-OCR prescription reading service launched in January 2022 that reads paper and electronic prescriptions with 99%+ claimed accuracy in approximately 10 seconds and outputs structured data directly to pharmacy receipt computers. Yakumaru Kenta is deployed at over 7,000 pharmacy stores nationwide and has processed over 100 million cumulative prescriptions as of November 2025, reaching 5 million monthly reads by July 2025. The company has expanded into an end-to-end Smart Pharmacy (スマート薬局) platform comprising four interconnected terminals for patient self-check-in, staff management, call display, and AI-OCR, supplemented by a free pill-counting app (Yakumaru Kazuko) and a municipal vaccine allocation app (Waktoru). NeoX generates revenue primarily through subscription fees for the AI-OCR service and Smart Pharmacy system, technology licensing to pharmacy software vendors (EM Systems, WEMEX, OZ), and freemium consumer app monetization.
NeoX distributes through direct enterprise sales to pharmacy chains (Welcia, Sugi, Kusuri no Fukutaro, Japan Medical System, Qol), integration partnerships with dominant Japanese pharmacy platform vendors (WEMEX Pharnes, EM Systems MAPs, OZ Pas-IS, Kakehashi Pocket Musubi, MG-DX, MICIN, Ubie), and app store distribution for consumer-facing tools. The company has been selected as an IT Introduction Support Business Operator under the government's Digitalization/AI Introduction Subsidy 2026 and has begun expanding into hospitals (joint research with St. Marianna University) and elderly care facilities (Mizuno Elderly Care). Named customers span large enterprise chains and mid-market independents; no disclosed revenue, headcount, or venture funding figures appear in available materials.
NeoX firmographics
Firmographics- Name
- NeoX
- Legal name
- NeoX株式会社
- Website
- https://neox-inc.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Short description
- NeoX (NeoX株式会社) is a Japanese AI company that provides AI-OCR prescription reading and Smart Pharmacy workflow automation to over 7,000 pharmacy stores in Japan, powered by its proprietary MoAir visual understanding platform.
- Ownership category
- akta.pro rank
NeoX industry classification
Industry- Product category
- Pharmacy Automation Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Pharmacy Information Systems (PIS) & Dispensing Workflow (HLACAKAC)
- akta.pro secondary industries
- Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH), Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)
Keywords
Where NeoX is headquartered
LocationHeadquarters
- HQ city
- Tokyo (Shibuya)
- HQ country
- Japan
- HQ region
- Asia
Offices2 records
Markets served
NeoX business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- AI-OCR Prescription Reading Service (薬師丸賢太): SaaS subscription model for prescription OCR reading. pharmacies pay for the AI-OCR service that reads prescriptions and inputs data into receipt computers. Pricing is quote-based for enterprise customers, with the service deployed across over 7,000 stores nationwide.
- Smart Pharmacy System (スマート薬局): Integrated pharmacy management platform including reception automation, patient management, and calling systems. Sold as an integrated solution to pharmacy chains.
- Free Pill Counting App (薬師丸数子): Free smartphone app for pill counting. Serves as a customer acquisition tool that drives adoption of the paid prescription reading service.
- Partnership/Technology Licensing: Technology licensing and co-development partnerships with pharmacy system vendors such as EM Systems (MAPs option prescription reader) and Wimex (Pharnes integration).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | AI-OCR prescription reading service for pharmacies |
| Freemium | Pay-as-you-go | Free pill counting app |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels5 records
NeoX product offering
Product offeringCore offering
NeoX develops and sells AI-powered visual understanding software for pharmacy automation. Its primary product, Yakumaru Gentaro, is an AI-OCR service that reads paper prescriptions and automatically inputs data into pharmacy receipt computers, deployed at over 7,000 pharmacies in Japan. The company also sells the Smart Pharmacy integrated platform, free pill-counting app Yakumaru Kazuko, and the underlying MoAir AI platform for object recognition and OCR. Revenue is primarily generated through subscription fees from pharmacy chains and technology licensing to pharmacy system vendors.
Product overview
NeoX offers a portfolio of AI-powered visual understanding and pharmacy automation products centered on two main platforms. MoAir is a cross-platform AI model creation framework enabling smartphone-based object recognition, OCR, and 1D/2D code scanning without deep learning expertise. The pharmacy suite, anchored by 薬師丸賢太 (AI-OCR prescription reading), spans the full pharmacy operation through スマート薬局 (Smart Pharmacy — an integrated platform combining 薬師丸撫子 for patient self-check-in, 薬師丸広司 for staff management, 薬師丸鈴音 for patient notification, and 薬師丸賢太 for prescription reading), supplemented by the free tablet counting app 薬師丸数子. NeoX also provides specialized tools like ワクトル for vaccine allocation and EMシステムズ technology licensing for prescription reading.
Differentiator
Problem solved
Functional benefit
Brands
- MoAir: AI platform for object recognition, OCR, and 1D/2D code scanning accessible via smartphone
- 薬師丸賢太 (Yakumaru Kenta)
- スマート薬局 (Smart Pharmacy)
- 薬師丸数子 (Yakumaru Kazuko)
- ワクトル (Waktoru)
- 薬師丸撫子 (Yakumaru Nadeshiko)
- 薬師丸広司 (Yakumaru Koji)
- 薬師丸鈴音 (Yakumaru Suzuki)
Products and services
- MoAir AI Platform A smartphone-based AI platform that enables users without AI expertise to create professional-grade visual understanding models. Combines object recognition, OCR, and 1D/2D code scanning into a single cross-platform solution with automatic neural network weight determination and GUI-based operation.
- Yakumaru Gentaro (薬師丸賢太) AI-OCR Prescription Reading Service AI-OCR prescription input support service for dispensing pharmacies. Scans paper prescriptions, uses AI to read and extract prescription content with 99%+ accuracy in approximately 10 seconds, auto-complements missing information, and outputs directly to pharmacy receipt computers. Deployed at 7,000+ stores nationwide with 100M+ cumulative prescription reads.
- Smart Pharmacy (スマート薬局) Next-generation pharmacy management platform that connects reception through dispensing to patient notification. Composed of four interconnected terminals enabling reception automation, cross-store remote medication guidance, and full pharmacy workflow digitization.
- Yakumaru Kazuko (薬師丸数子) Free Pill Counting App Free smartphone app that uses AI camera technology to instantly count loose pills within 1 second. Works offline without internet connection. Serves as a customer acquisition funnel driving adoption of the paid Yakumaru Gentaro prescription reading service.
- Waktoru (ワクトル) Vaccine Allocation Support App Smartphone app for municipalities to support vaccine subdivision allocation. Uses MoAir's object recognition technology for vial identification and automatic counting, with voice control for hands-free operation and end-to-end vaccine tray traceability via QR code scanning.
- MoAir Object Recognition SDK Software development kit enabling developers to embed MoAir's object recognition capabilities into their own applications. Allows non-engineers to create professional-grade machine learning models for object recognition accessible via web browser.
- MAPs Option Prescription Reader (EM Systems OEM) OEM prescription reading system developed jointly with EM Systems using NeoX's AI and medical-specialized OCR technology. Sold as an option to pharmacies using EM Systems' receipt computers.
Quantifiable outcome
- Reading accuracy of 99%+
- +7 more outcomes
Companies that use NeoX
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles5 records
NeoX technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
AI capability8 records
Feature8 records
NeoX partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- Ubie CorporationcoreNeoX and Ubie have integrated 'Yakumaru Kenta' with Ubie's 'Reserve with Google' pharmacy reservation service. This enables automatic prescription data reception and receipt computer input when patients book pharmacy appointments through Google Search. The service is initially available at approximately 300 pharmacies in Tokyo, Kanagawa, and Chiba, with plans to expand nationwide to over 7,000 stores.
- Major Pharmacy Chains (Qol, Kusuri no Fukutaro, Japan Medical System)coreNeoX and three major pharmacy chains (Qol, Kusuri no Fukutaro, and Japan Medical System) conducted an inspection tour of China's most advanced medical tech and pharmacy DX sites to explore the potential of 'Physical AI' for solving pharmacy labor shortages.
- St. Marianna University Yokohama City Seibu Hospital (聖マリアンナ医科大学横浜市西部病院)coreNeoX and St. Marianna University Yokohama City Seibu Hospital began joint research on an AI-assisted medication history registration support system using high-precision medical AI technology. The system will run on a fully offline on-premises AI-OCR system completely isolated from external networks, compliant with strict medical site regulations.
- MICIN CorporationcoreNeoX and MICIN integrated 'Yakumaru Kenta' with MICIN's online medication guidance service 'Clon Medication Support'. This enables automatic prescription data import to receipt computers when patients receive online medication guidance at 'Kusuri no Fukutaro' pharmacies in the Tokyo metropolitan area.
- OZ CorporationcoreNeoX and OZ expanded their partnership to integrate 'Smart Pharmacy' with 'Pas-IS' remote input service. This enables prescription input operations to be performed remotely (at input centers or other stores), significantly reducing the workload of pharmacy staff.
- Kakehashi CorporationcoreNeoX and Kakehashi built a new automated prescription input workflow integrating 'Yakumaru Kenta' with Kakehashi's patient follow-up system 'Pocket Musubi'. Prescription images sent through Pocket Musubi are automatically received, parsed by Yakumaru Kenta, and reflected in receipt computers. Full operation started May 13 at Welcia Pharmacy and Sogo Medical stores.
- Wimex CorporationcoreNeoX integrated 'Yakumaru Kenta' with Wimex's insurance pharmacy system 'Pharnes' series. The integration enables automatic electronic prescription reading and information retrieval from the Electronic Prescription Management Service. This unifies prescription reception operations regardless of whether prescriptions are paper or electronic.
- Sugi Pharmacy (株式会社スギ薬局)coreNeoX integrated 'Yakumaru Kenta' with Sugi Pharmacy's smartphone app 'Sugi Smartphone Medication' through API. Prescription images sent via the app are automatically received and parsed by Yakumaru Kenta, eliminating the need for printing and manual input.
- OZ CorporationcoreNeoX integrated 'Yakumaru Kenta' with OZ's remote prescription input service 'Pas-IS' for chain pharmacies. This enables prescription images scanned at individual stores to be processed at remote input centers, allowing franchise-wide optimization of prescription input operations and resource reallocation.
- Fujitsu LimitedminorNeoX was selected for the FUJITSU ACCELERATOR program (8th term) and participated in a pitch contest, demonstrating MoAir's object recognition and robot vision capabilities to Fujitsu's business leaders.
- SB Cloud / Alibaba GroupminorNeoX participated in the 10th AI Hands-On event organized by AIB Association with SB Cloud and Alibaba Group. NeoX's representative presented MoAir technology and participants experienced machine learning and recognition using MoAir.
- East Transit Japan (東渡日本)minorNeoX's real estate service 'Kami Ichi Byo-san' signed a intermediary cooperation agreement with East Transit Japan to jointly develop the Japanese real estate investment market.
- CANBOT (北京康力優藍ロボット技術有限公司)minorNeoX and CANBOT signed a strategic cooperation agreement in Chongqing. The partnership aimed to leverage each company's advantages in technology and market development, deepen comprehensive strategic cooperation, promote business innovation, and achieve win-win development.
Scale indicators11 records
Recent moves8 records
Expansion highlights6 records
NeoX competitors and assessment
Company assessmentDirect peers
- WEMEX (Pharnes): WEMEX's Pharnes is Japan's leading insurance pharmacy management system and a direct integration partner of NeoX. It competes in the same pharmacy IT workflow layer where Yakumaru Gentaro operates and could plausibly internalize AI-OCR capabilities.
- EM Systems: EM Systems ships the MAPs pharmacy receipt-computer platform and licenses NeoX's AI-OCR for its 'MAPs option Prescription Reader'. It is both a channel partner and the closest in-house competitor on the prescription-reading layer.
- OZ Corporation (Pas-IS): OZ's Pas-IS remote pharmacy-input service competes and integrates with Yakumaru Gentaro, centralizing prescription data capture across chain pharmacies. The overlap in prescription-data handling makes it a direct competitor for chain-pharmacy automation budgets.
Emerging players
- Kakehashi: Kakehashi's Pocket Musubi patient follow-up system integrates with Yakumaru Gentaro for automated prescription input. It is adjacent rather than directly competing, but is expanding into pharmacy workflow digitization where NeoX also operates.
- Ubie: Ubie's Reserve with Google pharmacy reservation service plugs into Yakumaru Gentaro for prescription data ingestion. As a patient-side platform, Ubie is complementary today but could move further into pharmacy operations software over time.
- MICIN: MICIN's online medication guidance service Clon Medication Support integrates with Yakumaru Gentaro at Kusuri no Fukutaro. It is an adjacent digital-health player increasingly touching the pharmacy workflow stack.
Broad incumbents
- Omnicell: Omnicell is a US-listed leader in medication management and pharmacy automation across retail, hospital and long-term-care pharmacies. While focused on hardware/automation rather than AI-OCR, it competes for the same pharmacy digitization budget globally.
- Surescripts: Surescripts operates the dominant US ePrescribing network and is progressively layering clinical intelligence and prior authorization tools. It is the closest incumbent in prescription-data infrastructure outside Japan.
- DrFirst: DrFirst provides ePrescribing, medication history and clinical messaging solutions to hospitals and pharmacies in North America. It is a comparable broader-incumbent in digital medication-management workflows.
- Becton Dickinson (BD): BD's Medical and Life Sciences segments include medication management and pharmacy automation solutions. As a global healthcare conglomerate, BD is a broad-incumbent competing for pharmacy and hospital IT spend.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
NeoX social profiles
Digital presenceNeoX compliance and trust
Trust signalCompliance5 records
NeoX financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeoX leadership team
Management profileNumber of profiles
Profiles3 records
NeoX funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeoX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeoX
What does NeoX do?
NeoX develops and sells AI-powered visual understanding software for pharmacy automation. Its primary product, Yakumaru Gentaro, is an AI-OCR service that reads paper prescriptions and automatically inputs data into pharmacy receipt computers, deployed at over 7,000 pharmacies in Japan. The company also sells the Smart Pharmacy integrated platform, free pill-counting app Yakumaru Kazuko, and the underlying MoAir AI platform for object recognition and OCR. Revenue is primarily generated through subscription fees from pharmacy chains and technology licensing to pharmacy system vendors.
Is NeoX a public or private company?
NeoX is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NeoX founded?
NeoX was founded in 2016.
Where is NeoX based?
NeoX is headquartered in Tokyo (Shibuya), Japan, in the Asia region.
How does NeoX make money?
Four revenue lines are on record. AI-OCR Prescription Reading Service (薬師丸賢太) is the primary driver. The others are smart Pharmacy System (スマート薬局), free Pill Counting App (薬師丸数子) and partnership/Technology Licensing.
Who are NeoX's main competitors?
Direct peers on record are WEMEX (Pharnes), EM Systems and OZ Corporation (Pas-IS). Emerging players are Kakehashi, Ubie and MICIN. Broad incumbents are Omnicell, Surescripts, DrFirst and Becton Dickinson (BD).
Does NeoX have an API?
Yes. Yakumaru Gentaro provides API connectivity enabling third-party pharmacy apps and services to send prescription images directly for AI-OCR parsing and automatic input into pharmacy systems (receipt computers). Partner apps include くすりの福太郎 (Kusurinofukutaro), スギスマホでお薬 (Sugi Pharmacy), 薬急便 (MG-DX), and others. The API enables automatic receipt of prescription images from patient-facing apps, AI parsing, and direct relay of structured data to pharmacy management systems. Developer documentation is at yakumaru.ai.
What industry is NeoX in?
NeoX's product category is Pharmacy Automation Software. Its primary akta.pro industry code is HLACAKAC, Pharmacy Information Systems (PIS) & Dispensing Workflow, with a secondary code of HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools. Its NAICS code is 5132 and its SIC code is 7372.